Total Visits

Views
The ... 586

Total Visits Per Month

April 2025May 2025June 2025July 2025August 2025September 2025October 2025
The ... 18 12 28 15 7 7 6

File Visits

Views
The Cardiovascular Benefits of Empagliflozin, A Sodium Glucose Cotransporter Inhibitor Is NHE1 a Viable Target.pdf 249

Top country views

Views
United States 290
China 68
Singapore 39
Taiwan 17
Japan 14
Qatar 12
Australia 11
Germany 10
United Kingdom 10
Ireland 10

Top cities views

Views
Colorado Springs 48
Ashburn 37
Sherman Oaks 17
Taipei 13
Oakland 11
Shanghai 11
Singapore 11
Doha 10
Dublin 10
Giza 8